Sante Ventures

Santé Ventures is a healthcare and life science venture capital firm that invests exclusively in early-stage companies developing new medical technologies or healthcare delivery models.^[1] The firm, which is based in Austin, Texas, was founded in 2006 and has $281 million in capital under management.

Team

• Kevin Lalande, Managing Director
• Joe Cunningham, MD, Managing Director
• Doug French, Managing Director
• Casey Cunningham, MD, Chief Scientific Officer
• Louis Bock, Venture Partner
• James Eadie, MD, Principal
• Bill Paape, Chief Financial Officer
• Derek Mazur, Senior Analyst
• Julie Rhee, Director of Marketing and Investor Relations^[2]

References

External links

• Santé Ventures (company website)

Private equity and venture capital
Basic investment types	Buyout Venture Mezzanine Growth Secondaries Equity co-investment
History	History of private equity and venture capital Early history of private equity Private equity in the 1980s Private equity in the 1990s Private equity in the 2000s
Terms and concepts	Buyout Financial sponsor Management buyout Divisional buyout Buy–sell agreement Leveraged recapitalization Dividend recapitalization Venture Angel investor Business incubator Post-money valuation Pre-money valuation Seed money Startup company Venture capital financing Venture debt Venture round Structure Private equity firms and funds Limited partnership Limited liability company Carried interest Management fee Publicly traded private equity Business Development Company Venture capital trust Private investment in public equity (PIPE) Pledge fund
Investors	Corporations Institutional investors Pension funds Insurance companies Fund of funds Endowments Foundations Investment banks Merchant banks Commercial banks High-net-worth individuals Family offices Sovereign wealth funds Crowdfunding
Related financial terms	AUM Cap table Capital call Capital commitment Capital structure Distribution waterfall EBITDA Envy ratio High-yield debt IPO IRR Leverage Liquidation preference M&A PME Taxation of private equity and hedge funds Undercapitalization Vintage year
Private equity and venture capital investors Private equity firms Venture capital firms Angel investors Portfolio companies